Observational studyMedicine2026
The relationship between the severity of depression in postmenopausal women and the incidence of osteoporosis and subsequent fractures: A cross-sectional observational study.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postmenopausal women experience declining estrogen levels that create a close association between the incidence of osteoporosis and osteoporotic fractures and the severity of depression, with recent evidence suggesting that depression may further exacerbate bone loss and fracture risk through influences on bone metabolism, lifestyle factors, and medication adherence. To evaluate the relationship between depression severity, bone mineral density, and fracture events, we conducted a combined cross-sectional and prospective cohort study of 245 postmenopausal women. Depression severity was measured using the HAMD-17 scale, bone mineral density was assessed by dual-energy X-ray absorptiometry, and fracture events were confirmed radiographically. Participants were stratified by age, menopause age, body mass index, smoking history, previous fracture history, and comorbidities to assess the impact of depression severity on osteoporosis and fracture risk. Our results demonstrated that depression severity showed significant inverse correlations with lumbar spine bone mineral density (odds ratio = 0.55, 95% confidence interval: 0.40-0.76, P < .001) and hip bone mineral density (odds ratio = 0.68, 95% confidence interval: 0.52-0.89, P < .005), and was positively associated with the incidence of osteoporotic fractures (odds ratio = 3.42, 95% confidence interval: 2.58-4.53, P < .001). Multivariate logistic regression confirmed that depression severity was independently associated with osteoporosis (odds ratio = 2.85, 95% confidence interval: 2.12-3.82, P < .001), while Cox regression analysis showed that it significantly increased fracture risk (hazard ratio = 2.90, 95% confidence interval: 2.10-4.00, P < .001). Subgroup analyses revealed more pronounced associations in women with longer postmenopausal duration exceeding 5 years, lower body mass index below 24 kg/m2, and those with comorbid diabetes. These findings indicate that depression severity in postmenopausal women is significantly associated with reduced bone density, increased prevalence of osteoporosis, and higher fracture rates, offering new strategies for managing the comorbidity of depression and osteoporosis in this population and highlighting the necessity for integrated mental and skeletal health interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.